Operator of a biotechnology company intended to make materials that help improve the world.
Operator of a biotechnology company intended to make materials that help improve the world.
Environmental Services (B2B)📍 Huntington Beach, CAFounded 2003
Current Valuation
$705.13M
as of 2020-Q3
PRIVATE
QL Price
$705.13M
0% vs last round
QuantLogix's current estimate for Newlight Technologies, published 2026-09-27 — in line with the last disclosed round of $705.13M (2020-Q3).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$705.13M
2020-Q3
weight 0.02
How this price has held up
No round has priced for Newlight Technologies since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Newlight Technologies, 2026-09-27 (fbeffbf015ae4fcc).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Newlight Technologies going public?
No. Newlight Technologies is private and has not filed to go public. There is no S-1 on file.
What is Newlight Technologies' valuation in 2026?
Newlight Technologies is valued at $705.13M as of 2020-Q3, set by its Series F ($45.13M, Sep 2020). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Newlight Technologies filed an S-1?
No public S-1 is on file for Newlight Technologies.
How much has Newlight Technologies raised?
Newlight Technologies has raised $213.61M in total, most recently a Series F of $45.13M in Sep 2020.
Is Newlight Technologies publicly traded — can you buy Newlight Technologies stock?
No. Newlight Technologies is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Newlight Technologies on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2003
HQ
Huntington Beach, CA
Employees
124
Total Raised
$213.61M
Last Round
Series F — $45.13M (Sep 2020)
IPO Status
private
Fundraising Status
Series F · $45.13M · 6y ago
privateTotal raised $213.61M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$45.13M
Sep 2020
—
$705.13M
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Newlight Technologies — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-19. Re-checked weekly.
Talent Signal
No public careers page or job board could be found for Newlight Technologies as of 2026-09-16. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2020-Q3. Refreshed quarterly.